Literature DB >> 1688815

Morphological effects of aspirin and prostaglandin on the canine gastric mucosal surface. Analysis with a phospholipid-selective cytochemical stain.

Y C Kao1, P J Goddard, L M Lichtenberger.   

Abstract

An iodoplatinate technique that selectively stains phospholipid was used to evaluate morphologically the effects of aspirin and 16,16-dimethyl prostaglandin E2 on canine gastric mucosa in an in vitro Ussing chamber system. The association between these morphological alterations and the changes in mucosal surface hydrophobicity as determined by contact angle analysis was also investigated. Prostaglandin (1 microgram/ml) did not alter aspirin-induced cell injury, although it reduced (45%) the detachment of damaged cells from the lamina propria. Mucus release appeared to be stimulated independently both by aspirin and prostaglandin treatment and by the blotting and drying procedure routinely performed before contact angle analysis. When an extracellular mucus gel coat was present, it contained numerous iodoplatinate-reactive vesicles and myelinated or lamellated structures. Iodoplatinate-reactive substances also appeared at the luminal surface of the mucus gel as a filamentous band. This band of reactivity was frequently seen after simultaneous treatment with prostaglandin and aspirin but only sporadically observed after aspirin treatment alone. The hydrophobic nature of the canine gastric mucosa under the above experimental conditions correlated well (r = 0.743, p less than 0.005) with the percentage of mucosal surface covered by this filamentous band, and less so with the density of iodoplatinate-reactive structures within the mucus gel. We conclude that phospholipid structures in the mucus gel may account for the hydrophobic nature of the gastric mucosal surface and the ability of damaging and "cytoprotective" agents to influence both surface wettability and barrier integrity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1688815     DOI: 10.1016/0016-5085(90)90278-9

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  13 in total

1.  Gastric surfactant and the hydrophobic mucosal barrier.

Authors:  B A Hills
Journal:  Gut       Date:  1996-11       Impact factor: 23.059

2.  Effect of salicylate on the elasticity, bending stiffness, and strength of SOPC membranes.

Authors:  Yong Zhou; Robert M Raphael
Journal:  Biophys J       Date:  2005-06-10       Impact factor: 4.033

3.  In vitro recovery of canine gastric mucosal surface hydrophobicity and potential difference after aspirin damage.

Authors:  P J Goddard; L M Lichtenberger
Journal:  Dig Dis Sci       Date:  1995-06       Impact factor: 3.199

4.  Effect of indomethacin on bile acid-phospholipid interactions: implication for small intestinal injury induced by nonsteroidal anti-inflammatory drugs.

Authors:  Yong Zhou; Elizabeth J Dial; Rand Doyen; Lenard M Lichtenberger
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-03-04       Impact factor: 4.052

5.  Surface hydrophobicity of the rat colonic mucosa is a defensive barrier against macromolecules and toxins.

Authors:  A Lugea; A Salas; J Casalot; F Guarner; J R Malagelada
Journal:  Gut       Date:  2000-04       Impact factor: 23.059

6.  Gastroprotective effect of ranitidine bismuth citrate is associated with increased mucus bismuth concentration in rats.

Authors:  S Tanaka; P H Guth; G Paulsen; J D Kaunitz
Journal:  Gut       Date:  1996-08       Impact factor: 23.059

7.  Phospholipase activity of Helicobacter pylori and its inhibition by bismuth salts. Biochemical and biophysical studies.

Authors:  A Ottlecz; J J Romero; S L Hazell; D Y Graham; L M Lichtenberger
Journal:  Dig Dis Sci       Date:  1993-11       Impact factor: 3.199

8.  Effect of a hydrophobic phospholipid lining of the gastric mucosa in bioadhesion.

Authors:  Jae Han Park; Joseph R Robinson
Journal:  Pharm Res       Date:  2007-09-06       Impact factor: 4.200

9.  Effect of sucralfate on components of mucosal barrier produced by cultured canine epithelial cells in vitro.

Authors:  J M Scheiman; E R Kraus; K Yoshimura; C R Boland
Journal:  Dig Dis Sci       Date:  1992-12       Impact factor: 3.199

10.  Clinical trial: comparison of ibuprofen-phosphatidylcholine and ibuprofen on the gastrointestinal safety and analgesic efficacy in osteoarthritic patients.

Authors:  F L Lanza; U K Marathi; B S Anand; L M Lichtenberger
Journal:  Aliment Pharmacol Ther       Date:  2008-06-11       Impact factor: 8.171

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.